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Background: Metabolic syndrome (MS) is known to increase the risk of various cardiometabolic diseases and in-
sulin resistance (IR) has known to have central role in the development of MS. Many surrogate indices of IR have 
been proposed and the detection of MS might be a suitable model for assessing the accuracy of surrogate indices. 
The aims of our study are to invest the most appropriate index by assessment of the diagnostic capacity of IR among 
each surrogate index and identifying cut-off values for discriminating uncomplicated MS in Korean adults.
Methods: A cross-sectional study was performed, assessing 294 Korean adults, 85 of whom were diagnosed with 
uncomplicated MS. The sensitivities and specificities of five surrogate IR indices were compared to discriminate 
MS from healthy subjects; these included fasting serum insulin, homeostasis model assessment–insulin resistance 
index, quantitative insulin sensitivity check index, McAuley index, and Disse index. Correlations between each in-
dex value were assessed using Pearson’s and Spearman’s correlation methods.
Results: The McAuley index showed the highest area under the curve (0.85), specificity (86.12%), accuracy 
(82.31%), positive predictive value (68.13%), and negative predictive value (88.67%) to distinguish MS, with a cut-off 
point of 5.3 defined. Correlation coefficients of the five indices showed that the McAuley index had the strongest 
correlation with IR.
Conclusion: The McAuley index showed the best accuracy in the detection of MS as a surrogate marker of IR. To 
establish more effective and accurate standards of measuring IR, comprehensive and multi-scaled studies are re-
quired.
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INTRODUCTION
Metabolic syndrome (MS) is clinically identified as a cluster of cardio-
vascular risk factors and metabolic imbalances such as central obesity, 
dyslipidemia, impaired glucose tolerance and dysregulation of blood 
pressure.1) MS increases the risk of cardiometabolic diseases, includ-
ing type II diabetes and cardiovascular disease.2) Furthermore, the 
prevalence of MS is increasing steadily in several Asian countries3) ow-
ing to the influence of socioeconomic westernization, resulting in 
problems such as increasing obesity4,5) and reduced physical activity.6) 
According to data from the Korean National Health and Nutrition Ex-
amination Survey (1998–2007), the age-adjusted prevalence of MS in 
Korean adults has rapidly increased in recent years, from 24.9% in 
1998 to 31.3% in 2007.5) Although the precise mechanism of MS patho-
genesis is still unknown, many studies have revealed that insulin resis-
tance (IR) and related factors have a central role in the development of 
metabolic dysfunction.7) As IR is a central factor in the development of 
MS, the detection of MS may provide a suitable model to assess the 
risk factors of IR, allowing preventative management of diseases such 
as diabetes.
 The hyperinsulinemic euglycemic clamp technique (HIEG) is gen-
erally accepted as the best available direct method to assess insulin 
sensitivity.8) However, this method has many clinical limitations, in-
cluding higher cost and the requirement for invasive procedures. Sev-
eral investigators have therefore proposed various indirect indices of 
IR (or insulin sensitivity) based on the measurement of biochemical 
values such as fasting blood glucose, fasting serum insulin, and lipid 
subtypes. The previously validated homeostasis model assessment-in-
sulin resistance index (HOMA-IR)9,10) and the quantitative insulin sen-
sitivity check index (QUICKI)11) are the most widely used surrogate 
measures of IR. However, these indices only reflect the feedback be-
tween fasting serum insulin and glucose. Recently, other studies have 
shown that insulin sensitivity can additionally be influenced by other 
factors such as excess adiposity and dyslipidemia.12) Based on these 
factors, alternative surrogate markers have been developed to measure 
IR, which better reflect lipid profiles such as triglyceride (TG) (McAuley 
index)13) or free fatty acid (FFA) (Disse index).14) Several recent investi-
gations have provided evidence that these indices better correlate with 
IR.
 There have been a number of studies reporting the influence of ra-
cial and environmental factors in insulin secretory capacity and insu-
lin sensitivity.15) The most common type of dyslipidemia in Korea has 
been reported to be hypertriglyceridemia,16) which is a considerable 
differentiating factor from western countries. Previously published 
comparative studies have assessed HOMA-IR, QUICKI, and fasting se-
rum insulin to measure IR using MS criteria among the Korean popu-
lation.17,18) However, there have been no studies reported to date that 
have investigated the efficacy of alternative indices for the detection of 
MS as a marker of IR among the Asian population.
 We therefore investigated the diagnostic capacity of several surro-
gate markers of insulin sensitivity including HOMA-IR, QUICKI, 
McAuley index, and Disse index to discriminate uncomplicated MS 
from normal controls. The ability of these indices to detect increased 
metabolic risks among Korean adults was assessed.
METHODS
1. Participants
A total of 492 participants were recruited for this study (79.7% female). 
Participants were recruited from those undergoing a medical check-
up at the division of family medicine in Gangnam Severance Hospital, 
between October 2005 and January 2008. Each participant was indi-
vidually asked to complete a simple questionnaire to evaluate the risk 
of metabolic or cardiovascular disease, including questions regarding 
past medical history, current medication, and smoking or alcohol con-
sumption. Smokers were defined as participants who currently or pre-
viously smoked cigarettes daily and those who had smoked ≥5 packs 
(100 cigarettes) of cigarettes during their lifetime before the study 
date.18) Non-smokers were defined as participants who had smoked <5 
packs of cigarettes during their lifetime or participants who had not 
smoked at all.19) Current drinkers were defined as participants who 
currently or previously drank alcohol less than once a month, but at 
least once a year, while non-drinkers were defined as participants who 
had not drank any alcohol for the last 12 months or had never drank 
throughout their lifetime.20)
 Subjects whose biochemical values or clinical information was not 
appropriate for the study were excluded, resulting in 198 subjects be-
ing excluded (Figure 1). Furthermore, 69 subjects were also excluded 
because they were under 18 years of age or provided insufficient self-
reported information during completion of the questionnaire. From 
the remaining 423 subjects, 89 were excluded owing to a current medi-
cal history of diabetes mellitus (DM), cardiovascular disease, renal 
disease, any cancer, or severe weight loss, defined as greater than 10% 
loss over the past 6 months. An additional 40 subjects were excluded 
owing to incomplete laboratory results, required to calculate insulin 
sensitivity indices. A total of 294 subjects (male 51 and female 243) 
were included in the study.
2. Measurements
Blood pressure was measured with a standardized mercury sphygmo-
manometer using the patient’s right arm after they had been in a sit-
ting position for at least 5 minutes. Blood pressure was measured in 
duplicate for each patient, and the average value was recorded. An-
thropometric measurements were performed by a single, well-trained 
examiner, with patients wearing light clothing without shoes. Body 
mass index (BMI) was calculated and waist circumference was mea-
sured horizontally at the umbilicus while the subject was standing.
 Following 12 hours of overnight fasting, blood samples were ob-
tained from the antecubital vein of each subject. Biomarkers of MS 
such as fasting glucose, total cholesterol, TG, high density lipoprotein 
cholesterol (HDLC), low density lipoprotein (LDL) cholesterol, and se-
rum FFA were measured using an ADVIA 1650 chemistry system (Sie-
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mens Medical Solutions, Tarrytown, NY, USA). White blood cell counts 
were quantified using an automated blood cell counter (ADVIA 120, 
Bayer, NY, USA). Serum fasting insulin levels were measured using a 
chemiluminescence immunoassay system (Roche, Indianapolis, IN, 
USA).
3. Definitions of Variables
MS was defined as fulfilling more than 3 of the following criteria based 
on the modified National Cholesterol Education Program Adult Treat-
ment Panel III definition and the Korean Society for the Study of Obe-
sity: (1) abdominal obesity: waist circumference ≥90 cm in men and 
≥85 cm in women; (2) TG ≥150 mg/dL; (3) low HDLC: <40 mg/dL in 
men and <50 mg/dL in women; (4) increased blood pressure: systolic 
blood pressure ≥130 mm Hg, diastolic blood pressure ≥85 mm Hg, or 
use of anti-hypertensive medications; and (5) impaired fasting glu-
cose: fasting glucose ≥100 mg/dL or the use of insulin or hypoglycemic 
medication.
 Five independent IR indices were assessed: HOMA-IR, QUICKI, 
McAuley index, Disse index, and fasting serum insulin levels. HOMA-
IR was calculated from the equation HOMA-IR=[fasting serum glucose 
(mmol/L)×fasting serum insulin (lU/mL)]/22.5]. For both fasting se-
rum insulin and HOMA-IR, increasing values corresponded to in-
creased IR. QUICKI was calculated from the equation QUICKI=1/{log 
[fasting serum insulin (IU/mL)]+log [fasting serum glucose (mg/dL)]}. 
The McAuley index was calculated from the equation McAuley=exp 
{2.63-0.28 ln [fasting serum insulin (IU/mL)]-0.31 ln [serum TG 
(mmol/L)]}. For both QUICKI and the McAuley index, increased val-
ues corresponded to decreased IR. The Disse index was calculated 
from the equation Disse=12×(2.5×{[serum HDLC/total cholesterol 
(mmol/L)]-[serum FFA (mmol/L)]})-fasting serum insulin (IU/mL). 
As the Disse index value is always calculated below zero, increase of 
the value corresponds to decrease in IR.
4. Statistical Analysis
All data were analyzed using SAS ver. 9.1 (SAS Institute Inc., Cary, NC, 
USA). Values are described as the mean±standard deviation for nor-
mally distributed data. Values for serum FFA were logarithmically 
transformed to eliminate the skewness of distribution. The clinical 
characteristics of the total study population and each subgroup were 
compared using an independent samples t-test and Mann-Whitney 
U-test for continuous variables or a chi-square test for categorical vari-
ables. P-values <0.05 were considered statistically significant.
 As all of the five IR indices showed statistically significant differences 
between the MS and non-MS subgroups, the accuracy of each index in 
the discriminating MS was further assessed using receiver-operating 
characteristic (ROC) analysis to obtain the area under the ROC curve 
(AUC). Comparison of AUCs was performed using DeLong method. 
Youden’s method was used to find an optimal cut-off point on the ROC 
curves to maximize the sensitivity and the specificity of each of IR indi-
ces.
Figure 1. The flowchart for subject selection.
Total recruited participants: 492 (100 male, 392 female)
69 Excluded (18 male, 51 female)
Under age: 24 (8 male, 16 female)
Lack of self-answers: 45 (10 male, 35 female)
Subjects remaining: 423 (82 male, 341 female)
89 Excluded: (29 male, 60 female)
Diabetes mellitus medication: 31 (11 male, 20 female)
Dyslipidemia medication: 25 (6 male, 19 female)
Renal disease: 3 (1 male, 2 female)
History of cardiovascular disease: 15 (8 male, 7 female)
Excessive weight loss: 3 (1 male, 2 female)
Others: 12 (2 male, 10 female)
Subjects remaining: 334 (53 male, 281 female)
40 Excluded for missing lab values (2 male, 38 female)
Subjects included in the analysis: 294 (51 male, 243 female)
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 The correlations of IR to each index were also assessed. According 
to a previously published study, the number of MS criteria was used to 
define IR severity,21) and correlation coefficients between each IR in-
dex and the number of MS criteria were assessed using both Pearson’s 
and Spearman’s tests. Values approaching 1 were indicative of a stron-
ger correlation.
RESULTS
A total of 294 participants (51 male and 243 female) were included in 
the study, with an age of 36.86±11.84 years and an average BMI of 
26.69±4.08 kg/m2. The MS group had higher BMI, waist circumference, 
higher incidence of smoking, current alcohol use, hypertension, and 
Table 1. Demographic characteristics of patients with or without metabolic syndrome
Characteristic Total (N=294) Metabolic syndrome (N=85) Non­metabolic syndrome (N=209) P­value
Age (y) 36.86±11.84 40.05±12.96 35.57±11.01
Sex
    Male   51 33   18
    Female 243 52 191
Weight (kg) 70.62±14.18 80.97±15.17 66.416±11.32 <0.001
Body mass index (kg/m2) 26.69±4.08 29.62±3.95 25.503±3.49 <0.001
Waist circumference (cm) 89.65±10.18 97.32±8.90 86.528±8.93 <0.001
Smoking
    Current smoking 33 25 8 <0.001*
    Non­smoking 261 60 201
Drinking
    Current drinking 45 28 17 <0.001*
    Non­drinking 249 57 192
Hypertension
    Current medication 39 39 0 <0.001*
    Non­medication 255 46 209
DM
    No DM history 290 81 209 <0.05*
    Newly diagnosed 4 4 0
Values are presented as mean±standard deviation assessed by independent two sample t­test or number.
DM, diabetes mellitus.
*Assessed by chi­square test.
Table 2. Clinical characteristics and insulin resistance indices of the participants based on the presence of metabolic syndrome
Measurements Total (N=294) Metabolic syndrome (N=85) Non­metabolic syndrome (N=209) P­value*
Clinical characteristics
    Systolic blood pressure (mm Hg) 120.69±14.02 132.34±15.63 115.96±9.97 <0.001
    Diastolic blood pressure (mm Hg) 72.74±10.63 78.68±13.32 70.33±8.15 <0.001
    Serum white blood cell (103/mm3) 6.43±1.66 7.02±1.67 6.19±1.60 <0.001
    Serum hemoglobin (g/dL) 13.74±2.15 14.35±1.71 13.48±2.26 <0.001
    Serum hematocrit (%) 40.53±4.46 42.70±4.58 39.65±4.09 <0.001
    Serum aspartate aminotransferase (IU/L) 21.79±12.27 26.84±18.28 19.74±7.83 <0.001
    Serum alanine aminotransferase (IU/L) 24.92±29.72 39.48±46.06 19.19±16.35 <0.001
    Fasting serum glucose (mg/dL) 91.18±12.48 97.29±15.68 88.70±9.88 <0.001
    Serum cholesterol (mg/dL) 183.76±31.92 191.77±37.74 180.50±28.59 <0.05
    Serum triglyceride (mg/dL) 113.21±84.41 178.24±110.92 86.76±50.99 <0.001
    Serum high density lipoprotein (mg/dL) 52.57±12.82 44.51±11.22 55.84±11.958 <0.001
    Serum FFA (µEq/L) 566.17±243.78 532.34±245.31 579.93±241.81 0.06†
    Fasting serum insulin (µU/mL) 9.54±9.15 14.63±12.02 7.48±6.65 <0.001
Insulin resistance indices
    Homeostasis model assessment­insulin resistance 3.57±3.072 1.68±1.602 <0.001
    Quantitative insulin sensitivity check index 0.58±0.108 0.71±0.147 <0.001
    McAuley 3.9±2.78 7.8±2.43 <0.001
    Disse index ­13.84±12.02 ­4.93±7.138 <0.001
Values are presented as mean±standard deviation, except for serum FFA for which the geometric mean is presented.
FFA, free fatty acid.
*Assessed by independent two­sample t­test. †Assessed by Mann­Whitney U­test.
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DM. Comparison of the patient demographic characteristics between 
MS and non-MS groups is shown in Table 1.
 Clinical laboratory characteristics were found to significantly differ 
across MS and non-MS groups (Table 2). Systolic and diastolic blood 
pressure, fasting glucose, total cholesterol, TG, fasting insulin, hemo-
globin, hematocrit, aspartate aminotransferase level, and alanine ami-
notransferase level were all significantly higher in MS group, while 
HDL cholesterol levels were significantly lower in MS group. The as-
sessment of IR indices revealed that HOMA-IR levels were significantly 
higher in the MS group, while QUICKI, McAuley, and Disse indices 
were significantly higher in non-MS group.
 ROC curves were generated for each index after adjustment with 
sex, age, BMI, smoking, and drinking habit (Figure 2). The AUC for all 
indices were larger than 0.75. The AUC for the McAuley index was sig-
nificantly greater (AUC=0.8538) than the AUCs for other indices. The 
second greatest AUC value was obtained using the Disse index 
(AUC=0.7771). However, post-hoc analyses revealed there were no 
statistical differences among each of the IR indices, except with the 
McAuley index (Table 3).
 Sensitivity, specificity, accuracy, positive predictive value (PPV), and 
negative predictive value (NPV) of each IR index for discriminating MS 
are shown in Table 4. Youden’s method was used to determine optimal 
cut-off values, maximizing the sum of sensitivity and specificity. The 
highest values of any index for specificity, accuracy, PPV and NPV 
were observed using the McAuley index with a cut-off value of 5.3, and 
these were found to be significantly greater when compared with the 
other indices. The distributions of index values calculated from the MS 
group and non-MS group are shown in Figure 3. 
 Assessment of the correlations between IR and each of the indices 
revealed that the McAuley index had the strongest correlation (the 
highest slope) across all groups (R=-0.6590) (Figure 3). The second 
strongest correlation was observed using the Disse index (R=-0.4816). 
The correlation comparison by Wolfe’s test confirmed there was sig-
nificant statistical difference between the McAuley and Disse coeffi-
cients (Figure 4F).
Table 3. Post­hoc analyses of the AUC of each insulin index
Index AUC (95% confidence interval) Overall P­value Post­hoc*
Fasting serum insulin 0.75 (0.69–0.81) <0.0001 Ref
Homeostasis model assessment­insulin resistance 0.76 (0.70–0.82) 0.12 Ref
Quantitative insulin sensitivity check index 0.76 (0.70–0.82) 0.11 0.99 Ref
McAuley 0.85 (0.80–0.90) <0.0001 <0.0001 <0.0001 Ref
Disse index 0.78 (0.72–0.84) 0.22 0.45 0.45 0.0004
AUC, area under curve; Ref, standard reference. 
*Post­hoc analyses were conducted using DeLong method. 
Table 4. The diagnostic performance of four insulin resistance indices
Index
Cut­off  
value*
Sensitivity %  
(95% CI)
Specificity %  
(95% CI)
Accuracy %  
(95% CI)
Positive predictive value 
% (95% CI)
Negative predictive 
value % (95% CI)
Homeostasis model 
  assessment­insulin resistance
>1.87 67.06 (57.07–77.05) 72.25 (66.18–78.32) 70.75 (65.55–75.95) 49.57 (40.43–58.70) 84.36 (79.04–89.68)
Quantitative insulin sensitivity 
  check index
≤0.61 67.06 (57.07–77.05) 72.73 (66.69–78.77) 71.09 (65.91–76.27) 50.00 (40.82–59.18) 84.44 (79.15–89.74)
McAuley ≤5.3 72.94 (63.50–82.39) 86.12 (81.44–90.81) 82.31 (77.95–86.67) 68.13 (58.56–77.71) 88.67 (84.31–93.03)
Disse index ≤­5.79 77.64 (68.79–86.50) 64.59 (58.11–71.08) 68.37 (63.05–73.68) 47.14 (38.87–55.41) 87.66 (82.47–92.86)
CI, confidence interval.
*Youden’s method was used to determine the optimal cut­off value.
Figure 2. ROC curves for the detection of metabolic syndrome. ROC, receiver­
operating characteristic; HOMA­IR, homeostasis model assessment­insulin 
resistance; QUICKI, quantitative insulin sensitivity check index.
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DISCUSSION
Using the diagnosis of MS as a marker of IR, our cross-sectional study 
showed that the McAuley index has the best accuracy for screening 
uncomplicated IR in Korean adults. Appropriate cut-off values for each 
index for were also identified in discriminating MS from non-MS sub-
jects.
 The prevalence of cardiometabolic diseases has been rapidly in-
creasing worldwide, and the detection of IR is considered important 
owing to its central role in the pathogenesis of metabolic disturbance. 
Therefore, tests to reliably measure IR will provide the first step in ef-
fective preventive management of individuals at high cardiovascular 
risk.22) Although HIEG is considered the gold standard for measuring 
IR directly, many other methods have been developed to overcome 
the clinical limitations of HIEG, such as technical demands, invasive 
procedure, and high costs. Among them, surrogate indirect indices 
that are calculated based on serum glucose and insulin level have 
been the most widely used. These include indices such as insulin to 
glucose ratio, HOMA-IR, and QUICKI. Several studies have previously 
reported a correlation between HIEG and HOMA-IR or QUICKI. How-
ever the correlation coefficients of these indices were reported to fall in 
the range from 0.5 to 0.6.23,24) Furthermore, these indices have several 
limitations in representing the whole range of IR. Firstly, the relation-
ship between fasting serum glucose and insulin mainly reflects hepatic 
glucose sensitivity, whereas HIEG mainly assesses peripheral glucose 
sensitivity.25) Secondly, it is debated that the secretory function of pan-
creatic beta cells may affect the value of HOMA-IR, although most of 
these studies did not discriminate DM patients.18,25) Many recent inves-
tigations have suggested additional adjusted surrogate indices that 
showed better correlations with HIEG. The McAuley index was devel-
oped by McAuley et al.13) in 2001 to identify the status of IR in the gen-
eral population, and comprised fasting serum insulin levels and serum 
TG. Furthermore, some studies have reported that the TG/HDL ratio 
correlates well with IR in the normal population or in patients with 
early stage MS.26) These findings support the notion that hepatic regu-
lation of glucose metabolism is also important in the development of 
IR in the non-DM population. Another study by Disse et al.14) suggest-
ed that the substitutive index using serum FFA (Disse index) provided 
the best accuracy to identify IR. Currently, many experts insist, howev-
er, that the suitable surrogate index should be ‘selected’ with consider-
ation of the individual aspects of the study being performed.25,27) In this 
study, we focused on the ability of newly suggested markers to screen 
for uncomplicated IR in individuals, and compared these with tradi-
tional IR markers.
Figure 3. Distribution curves for insulin resistance indices. Red curves (negative) represent non­MS groups, while dotted blue curves (MS) represent the MS groups. The 
horizontal axes show index value and vertical axes show the number of subjects. (A) Distribution of homeostasis model assessment­insulin resistance. (B) Distribution of 
quantitative insulin sensitivity check index. (C) Distribution of the McAuley index. (D) Distribution of the Disse index. MS, metabolic syndrome.
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 Several other studies have also identified the McAuley index to be a 
more accurate detection method for IR compared with other indices. 
The outcomes of our study are consistent with these previous investi-
gations. Ascaso et al.28) found that the McAuley index was more specif-
ic and sensitive in the assessment of IR compared to QUICKI. Another 
study assessing the non-diabetic offspring of diabetic individuals re-
ported the highest AUC for MS detection using the McAuley index.29) 
In a study of newly diagnosed subjects with type II DM, comparison of 
fasting serum insulin and the McAuley index to identify IR showed 
that both tests had high specificity but relatively low sensitivity, in 
Figure 4. Comparison of correlation coefficients between indices. Each index: Pearson’s correlation coefficient/Spearman’s correlation coefficient. (A) Insulin: 0.3718 
(<0.0001)/0.4460 (<0.0001). (B) HOMA­IR: 0.4061 (<0.0001)/0.4715 (<0.0001). (C) QUICKI: ­0.4649 (<0.0001)/­0.4684 (<0.0001). (D) McAuley: ­0.6590 
(<0.0001)/­0.6514 (<0.0001). (E) ­0.4816 (<0.0001)/­0.5592 (<0.0001). (F) Wolfe’s test. MS, metabolic syndrome; HOMA­IR, homeostasis model assessment­insulin 
resistance; QUICKI, quantitative insulin sensitivity check index; Ref, reference.
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agreement with the results of our study.30) Although many previous 
studies have compared the power of MS detection among IR indices, 
relatively few studies have assessed an Asian population. To our 
knowledge, this is the first study that investigates the efficacy of alter-
native indices including the McAuley and Disse indices in an Asian 
population.
 The identification of the McAuley index as the most effective in de-
tecting IR additionally provide insights into the pathophysiology of 
both IR and MS. Our results provide evidence that dysregulation of se-
rum lipid metabolism, especially TG, may be the main factor of early 
stage IR. When the quantity of glucose entering the liver exceeds the 
hepatocyte glycogen storing capacity, insulin promotes the conversion 
of all excess glucose into fatty acids that are subsequently packaged as 
TG.31) Many previous studies have demonstrated that IR and the ac-
companying hyperinsulinemia can directly affect lipoprotein metabo-
lism.32) Increased TG levels, as the result of hyperinsulinemia, also di-
rectly cause pancreatic beta-cell dysfunction, due to the accumulation 
of TG inside the cells. Consequently, these cascades may establish a 
cycle driving aggravating insulin dysregulation. The postprandial hy-
perlipidemia (higher TG, lower HDL, and lower LDL) characteristic of 
type II DM patients is a good example. Based on these facts and our 
results, measuring dyslipidemia is likely to be a good reflection of early 
uncomplicated, metabolic dysfunction, even in those still able to pre-
serve hepatic glucose uptake.
 Our study has several limitations. Firstly, HIEG was not performed 
in our study, and thus, IR could not be directly confirmed. Secondly, 
the cross-sectional design of our study limited the ability to determine 
disease causality. As we studied a small population who visited a hos-
pital for a health check-up, including for management obesity man-
agement, our results cannot be generalized to the entire population. 
Thirdly, women accounted for a larger proportion of participants than 
men. Further prospective large-scaled studies should be performed to 
determine the precise role of IR indices in detecting MS in the future.
 In conclusion, the McAuley index is the most reliable and accurate 
tool to detect MS as a marker of uncomplicated IR in Korean adults. 
Although we could not determine disease causality, our results collec-
tively suggest that the assessment of hepatic lipid metabolism, includ-
ing TG, may be useful in the detection of IR prevalence. Further studies 
are required to understand the clinical and pathophysiological signifi-
cance of our findings.
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